{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:16:01Z","timestamp":1780413361952,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Malignant peripheral nerve sheath tumours (MPNSTs) are highly aggressive Schwann cell-derived sarcomas, and they are either associated with neurofibromatosis type 1 (NF1) or sporadic. Our previous study found that high mobility group protein A2 (HMGA2) regulates NF1-MPNST growth through Musashi-2 (MSI2); however, whether MSI2 regulates MPNST metastasis and what the mechanism is remain unclear. Here, we demonstrated that the protein caveolin-1 (CAV1) directly interacts with MSI2 in human NF1-MPNST cells. Moreover, we discovered that knockdown of MSI2 induces CAV1 protein expression by inhibiting its ubiquitylation level in NF1-MPNSTs. In addition, CAV1 mediates the suppressive function of MSI2 in epithelial-mesenchymal transition, migration and invasion in vitro and metastasis in vivo. These results help to reveal the potential mechanisms of MSI2 as a target of antimetastatic treatment for human NF1-MPNST.<\/jats:p>","DOI":"10.1038\/s41419-020-2703-x","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T05:02:52Z","timestamp":1593493372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Knockdown of MSI2 inhibits metastasis by interacting with caveolin-1 and inhibiting its ubiquitylation in human NF1-MPNST cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Kang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"2703_CR1","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1158\/0008-5472.CAN-16-2643","volume":"77","author":"RD Dodd","year":"2017","unstructured":"Dodd, R. D. et al. NF1(+\/-) hematopoietic cells accelerate malignant peripheral nerve sheath tumor development without altering chemotherapy response. Cancer Res. 77, 4486\u20134497 (2017).","journal-title":"Cancer Res."},{"key":"2703_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ebiom.2016.06.007","volume":"9","author":"AV Patel","year":"2016","unstructured":"Patel, A. V. et al. An ShRNA screen identifies MEIS1 as a driver of malignant peripheral nerve sheath tumors. EBioMedicine 9, 110\u2013119 (2016).","journal-title":"EBioMedicine"},{"key":"2703_CR3","doi-asserted-by":"crossref","unstructured":"Shih, T. C. et al. Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumors. Neuro Oncol. 21, 1389\u20131400 (2019).","DOI":"10.1093\/neuonc\/noz093"},{"key":"2703_CR4","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1523\/JNEUROSCI.21-20-08091.2001","volume":"21","author":"S Sakakibara","year":"2001","unstructured":"Sakakibara, S., Nakamura, Y., Satoh, H. & Okano, H. Rna-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS. J. Neurosci. 21, 8091\u20138107 (2001).","journal-title":"J. Neurosci."},{"key":"2703_CR5","first-page":"678","volume":"63","author":"KM Gunter","year":"2011","unstructured":"Gunter, K. M. & McLaughlin, E. A. Translational control in germ cell development: a role for the RNA-binding proteins Musashi-1 and Musashi-2. IUBMB Life 63, 678\u2013685 (2011).","journal-title":"IUBMB Life"},{"key":"2703_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature17988","volume":"534","author":"RG Fox","year":"2016","unstructured":"Fox, R. G. et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature 534, 407\u2013411 (2016).","journal-title":"Nature"},{"key":"2703_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-16-1064","volume":"23","author":"K Guo","year":"2017","unstructured":"Guo, K. et al. The novel KLF4\/MSI2 signaling pathway regulates growth and metastasis of pancreatic cancer. Clin. Cancer Res. 23, 687\u2013696 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2703_CR8","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.1513616113","volume":"113","author":"AE Kudinov","year":"2016","unstructured":"Kudinov, A. E. et al. Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc. Natl Acad. Sci. USA 113, 6955\u20136960 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2703_CR9","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3892\/ijo.2016.3683","volume":"49","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells. Int. J. Oncol. 49, 1945\u20131952 (2016).","journal-title":"Int. J. Oncol."},{"key":"2703_CR10","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/cas.14035","volume":"110","author":"T Tsujino","year":"2019","unstructured":"Tsujino, T. et al. MicroRNA-143\/Musashi-2\/KRAS cascade contributes positively to carcinogenesis in human bladder cancer. Cancer Sci. 110, 2189\u20132199 (2019).","journal-title":"Cancer Sci."},{"key":"2703_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13046-019-1183-2","volume":"38","author":"K Yang","year":"2019","unstructured":"Yang, K. et al. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth. J. Exp. Clin. Cancer Res. 38, 185 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2703_CR12","first-page":"2054","volume":"54","author":"Y Gao","year":"2019","unstructured":"Gao, Y. et al. Simvastatin delays castrationresistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin1. Int. J. Oncol. 54, 2054\u20132068 (2019).","journal-title":"Int. J. Oncol."},{"key":"2703_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jcp.21474","volume":"217","author":"L Perrone","year":"2008","unstructured":"Perrone, L., Peluso, G. & Melone, M. A. RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes. J. Cell Physiol. 217, 60\u201371 (2008).","journal-title":"J. Cell Physiol."},{"key":"2703_CR14","first-page":"1287","volume":"40","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Caveolin1 enhances RANKLinduced gastric cancer cell migration. Oncol. Rep. 40, 1287\u20131296 (2018).","journal-title":"Oncol. Rep."},{"key":"2703_CR15","first-page":"537","volume":"54","author":"K Kamposioras","year":"2019","unstructured":"Kamposioras, K. et al. Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model. Int. J. Oncol. 54, 537\u2013549 (2019).","journal-title":"Int. J. Oncol."},{"key":"2703_CR16","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1038\/onc.2017.74","volume":"36","author":"L Mi","year":"2017","unstructured":"Mi, L. et al. The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells. Oncogene 36, 4323\u20134335 (2017).","journal-title":"Oncogene"},{"key":"2703_CR17","doi-asserted-by":"publisher","first-page":"37702","DOI":"10.1074\/jbc.M006657200","volume":"275","author":"F Galbiati","year":"2000","unstructured":"Galbiati, F., Volonte, D., Minetti, C., Bregman, D. B. & Lisanti, M. P. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3. J. Biol. Chem. 275, 37702\u201337711 (2000).","journal-title":"J. Biol. Chem."},{"key":"2703_CR18","doi-asserted-by":"publisher","first-page":"38121","DOI":"10.1074\/jbc.M008340200","volume":"276","author":"B Razani","year":"2001","unstructured":"Razani, B. et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121\u201338138 (2001).","journal-title":"J. Biol. Chem."},{"key":"2703_CR19","doi-asserted-by":"crossref","unstructured":"Sun, H. et al. USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK\/MAPK signaling pathway. EBioMedicine 48, 236\u2013247 (2019).","DOI":"10.1016\/j.ebiom.2019.08.061"},{"key":"2703_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-018-1007-9","volume":"38","author":"J Song","year":"2019","unstructured":"Song, J. et al. 14-3-3zeta inhibits heme oxygenase-1 (HO-1) degradation and promotes hepatocellular carcinoma proliferation: involvement of STAT3 signaling. J. Exp. Clin. Cancer Res. 38, 3 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2703_CR21","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1158\/0008-5472.CAN-16-1031","volume":"76","author":"X Mao","year":"2016","unstructured":"Mao, X. et al. Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma. Cancer Res. 76, 7242\u20137253 (2016).","journal-title":"Cancer Res."},{"key":"2703_CR22","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1158\/0008-5472.CAN-10-0900","volume":"70","author":"C Trimmer","year":"2010","unstructured":"Trimmer, C. et al. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin\/Src\/FAK signaling pathway. Cancer Res. 70, 7489\u20137499 (2010).","journal-title":"Cancer Res."},{"key":"2703_CR23","doi-asserted-by":"publisher","first-page":"7675","DOI":"10.1158\/0008-5472.CAN-06-4697","volume":"67","author":"L Cantiani","year":"2007","unstructured":"Cantiani, L. et al. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cancer Res. 67, 7675\u20137685 (2007).","journal-title":"Cancer Res."},{"key":"2703_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ebiom.2018.11.004","volume":"38","author":"P Kanlikilicer","year":"2018","unstructured":"Kanlikilicer, P. et al. Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer. EBioMedicine 38, 100\u2013112 (2018).","journal-title":"EBioMedicine"},{"key":"2703_CR25","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1016\/j.celrep.2017.11.034","volume":"21","author":"W Celus","year":"2017","unstructured":"Celus, W. et al. Loss of caveolin-1 in metastasis-associated macrophages drives lung metastatic growth through increased angiogenesis. Cell Rep. 21, 2842\u20132854 (2017).","journal-title":"Cell Rep."},{"key":"2703_CR26","first-page":"3882","volume":"61","author":"SA Tahir","year":"2001","unstructured":"Tahir, S. A. et al. Secreted caveolin-1 stimulates cell survival\/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61, 3882\u20133885 (2001).","journal-title":"Cancer Res."},{"key":"2703_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee, W. et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat. Genet. 46, 1227\u20131232 (2014).","journal-title":"Nat. Genet."},{"key":"2703_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/ng.3854","volume":"49","author":"LP Vu","year":"2017","unstructured":"Vu, L. P. et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat. Genet. 49, 866\u2013875 (2017).","journal-title":"Nat. Genet."},{"key":"2703_CR29","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1158\/1078-0432.CCR-16-2728","volume":"23","author":"AE Kudinov","year":"2017","unstructured":"Kudinov, A. E., Karanicolas, J., Golemis, E. A. & Boumber, Y. Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets. Clin. Cancer Res. 23, 2143\u20132153 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2703_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7517","volume":"6","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Transformation of the intestinal epithelium by the MSI2 RNA-binding protein. Nat. Commun. 6, 6517 (2015).","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.1038\/s41419-020-02816-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000}},{"DOI":"10.1038\/s41419-026-08903-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2703-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2703-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2703-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:26:55Z","timestamp":1780403215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2703-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["2703"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2703-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-020-02816-z","URL":"https:\/\/doi.org\/10.1038\/s41419-020-02816-z","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":10,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":11,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-026-08903-x","URL":"https:\/\/doi.org\/10.1038\/s41419-026-08903-x","order":13,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments using human samples were approved by the Review Board of Yangzhou University Affiliated Hospital, and all patients provided informed consent. All procedures involving animals were reviewed, and the protocols were approved by the Animal Care and Use Committee of Yangzhou University Affiliated Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval and consent to participate"}}],"article-number":"489"}}